1. Miller, D.S., et al. (2008) Pharmacol Rev 60, 196-209
2. Fellner, S., et al. (2002) J Clin Invest 110, 1309-1318
3. Kemper, E.M., et al. (2004) Eur J Cancer 40, 1269-1274
4. Bauer, B., et al. (2004) Mol Pharmacol 66, 413-419
5. Dauchy, S., et al. (2008) J Neurochem 107, 1518-1528
6. Nannelli, A., et al. (2009) Mol Cell Biochem
7. Ott, M., et al. (2009) J Pharmacol Exp Ther 329, 141-149
8. Bauer, B., et al. (2006) Mol Pharmacol 70, 1212-1219
9. Bauer, B., et al. (2007) Mol Pharmacol 71, 667-675
10. Hartz, A.M., et al. (2008) Faseb J 22, 2723-2733
11. Vogelgesang, S., et al. (2002) Pharmacogenetics 12, 535-541
12. Vogelgesang, S., et al. (2006) Acta Neuropathol (Berl) 111, 436-443
13. Vautier, S., and Fernandez, C. (2009) Expert Opin Drug Metab Toxicol 5, 1349-1358
14. Langford, D., et al. (2004) J Neuropathol Exp Neurol 63, 1038-1047
15. Bauer, M., et al. (2009) Eur J Clin Pharmacol 65, 941-946
16. Loscher, W., and Potschka, H. (2005) Nat Rev Neurosci 6, 591-602
17. Bauer, B., et al. (2008) Mol Pharmacol 73, 1444-1453
18. Hartz, A.M., et al. (2009) Drug News Perspect 22, 393-397
19. Hartz, A.M., et al. (2006) Mol Pharmacol 69, 462-470
20. Hartz, A.M., et al. (2004) Mol Pharmacol 66, 387-394
21. Greenberg, D.A., and Jin, K. (2005) Nature 438, 954-959